Several provisions in the recently adopted 2018-19 New York State Budget (the “Enacted Budget”) are intended to address the ongoing opioid crisis. As discussed in a prior post (here), some were focused on pharmaceutical manufacturers. Some of the most significant provisions
Trypanophobia—the fear of needles—played a significant role in a case brought against Rite Aid Pharmacy under the Americans with Disabilities Act (ADA). In Stevens v. Rite Aid Corp., the Second Circuit overturned a jury verdict awarding substantial damages to a Rite Aid pharmacist who was terminated after he said he could not perform immunization injections because of a needle
Continue Reading Pharmacy Chain Not Required To Reasonably Accommodate Needle-Phobic Pharmacist
The Second Circuit recently agreed to accept an interlocutory appeal to decide the question whether a violation of the False Claims Act’s “first-to-file” rule compels dismissal of the complaint or whether it can be cured by the filing of an amended pleading.
In United States ex rel. Wood v. Allergan, Inc., Relator John Wood brought FCA claims against Allergan,
Continue Reading Second Circuit Accepts Appeal of False Claims Act First-To-File Issues
Some of our colleagues at Farrell Fritz prepared an advisory with helpful information and links for families, individuals and businesses in need of disaster recovery assistance due to Hurricane Sandy or the subsequent storm.
We hope you weathered the storms safely. Please do not hesitate to contact us if we can be of assistance in any way.Continue Reading Disaster Recovery Advisory